
|
 |
The Institute of Environmental Science and Research Ltd (ESR) under contract with the Ministry of Health (MoH) contributes to the national public health surveillance effort.
This website provides access to selected New Zealand public health surveillance data and information.
We welcome the use of this surveillance data with the following acknowledgement, New Zealand surveillance data provided by ESR, funded by the Ministry of Health with the cooperation of the diagnostic laboratories.
Ministry of Health support enables ESR to provide some specific additional work, prioritised on the basis of national benefit and we are happy to collaborate with funded projects to mine the surveillance data.
Click Here for information on notifying a Sexually Transmitted Infection
Public Health Surveillance
ESR coordinates and collates information for several national surveillance systems. More
 |
Surveillance reports are available for notifiable diseases, influenza, sexually transmitted infections and chemical injuries.
|
 |
 |
The Antibiotic Reference Laboratory at ESR is responsible for the
national surveillance of antimicrobial resistance among human pathogens. More
|
 |
 |
ESR public health virology laboratory collates, analyses and reports all year round laboratory-based virological surveillance.
More
|
 |
 |
The Enteric Reference Laboratory is responsible for the confirmation of isolates of the following notifiable diseases Salmonellae, Shigellae, Vibrio cholerae O1 and VTEC. More
|
 |
 |
The Environmental Health Indicators (EHIs) project was commissioned by the Ministry of Health to develop a functional core set of environmental health indicators for New Zealand. More
|
 |
 |
Case report forms and instructions for notifiable diseases in EpiSurv, New Zealand's primary notifiable disease database. More
|
 |
 |
A national messaging system for Direct Laboratory Notification of notifiable disease.
More
|
 |
|
 |
 |
Surveillance |
•
Monthly Notifiable Disease Surveillance Report - Dec 2022
•
Tuberculosis in New Zealand: Annual Report 2019
•
Monthly Notifiable Disease Surveillance Report - Nov 2022
•
Meningococcal Disease Monthly Report Nov 2022
|
Antimicrobial Resistance |
• Antimicrobial susceptibility of invasive N. meningitidis, 2022 (Interim)
• Carbapenemase-producing organisms, line listing for 2022 as at 31 December
• Antimicrobial susceptibility of Salmonella, 2017-2019
• Antimicrobial susceptibility of invasive N. meningitidis , 2021
|
Virology |
• Influenza Vaccine Recommendations 2023
• Influenza surveillance in New Zealand 2021
• Influenza Vaccine Recommendations 2022
• Influenza Vaccine Recommendations 2021
|
Enteric Reference Laboratory |
•
Human Salmonella isolates, 2022 No.11, November
•
Human Salmonella isolates, 2022 No.10, October
•
Non-Human Salmonella Isolates, 2022 No. 11, November
•
Non-Human Salmonella Isolates, 2022 No. 10, October
|
 |
|